![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Mehta, Naveen K.; Pfluegler, Martin; Meetze, Kristan; Li, Bochong; Sindel, Isabelle; Vogt, Fabian; Marklin, Melanie; Heitmann, Jonas S.; Kauer, Joseph; Osburg, Lukas; Zekri, Latifa; Buehring, Hans-Joerg; Mueller, Stefanie; Hoerner, Sebastian; Baeuerle, Patrick A.; Michaelson, Jennifer S.; Jung, Gundram und Salih, Helmut R.
(2022):
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
In: Journal for Immunotherapy of Cancer, Bd. 10, Nr. 3, e003882
2016
Schmohl, Joerg U.; Nuebling, Tina; Wild, Julia; Kroell, Tanja; Kanz, Lothar; Salih, Helmut R. und Schmetzer, Helga
(2016):
Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML.
In: Journal of investigative Medicine, Bd. 64, Nr. 8: S. 1252-1260
Schlenk, Richard F.; Lübbert, Michael; Benner, Axel; Lamparter, Alexander; Krauter, Jürgen; Herr, Wolfgang; Martin, Hans; Salih, Helmut R.; Kündgen, Andrea; Horst, Heinz-A.; Brossart, Peter; Götze, Katharina; Nachbaur, David; Wattad, Mohammed; Köhne, Claus-Henning; Fiedler, Walter; Bentz, Martin; Wulf, Gerald; Held, Gerhard; Hertenstein, Bernd; Salwender, Hans; Gaidzik, Verena I.; Schlegelberger, Brigitte; Weber, Daniela; Döhner, Konstanze; Ganser, Arnold und Döhner, Hartmut
(2016):
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
In: Annals of Hematology, Bd. 95, Nr. 12: S. 1931-1942